Total Payments
$3,416
2024 Payments
$251.68
Companies
30
Transactions
126
Medicare Patients
479
Medicare Billing
$70,710
Payment Breakdown by Category
Food & Beverage$3,270 (95.7%)
Education$85.57 (2.5%)
Other$60.78 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,270 | 120 | 95.7% |
| Education | $85.57 | 3 | 2.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $60.78 | 3 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $773.26 | 18 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $507.45 | 12 | $0 (2022) |
| GENZYME CORPORATION | $295.36 | 10 | $0 (2019) |
| UCB, Inc. | $266.19 | 11 | $0 (2018) |
| Genentech USA, Inc. | $257.88 | 6 | $0 (2018) |
| Allergan Inc. | $194.98 | 4 | $0 (2017) |
| Supernus Pharmaceuticals, Inc. | $126.11 | 7 | $0 (2019) |
| Lilly USA, LLC | $107.38 | 6 | $0 (2024) |
| Eisai Inc. | $98.22 | 4 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $97.13 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $251.68 | 12 | Eisai Inc. ($98.22) |
| 2023 | $71.09 | 4 | Otsuka America Pharmaceutical, Inc. ($48.59) |
| 2022 | $45.11 | 2 | Teva Pharmaceuticals USA, Inc. ($28.65) |
| 2021 | $18.79 | 1 | Biogen, Inc. ($18.79) |
| 2020 | $238.95 | 2 | Biogen, Inc. ($124.98) |
| 2019 | $634.15 | 28 | Teva Pharmaceuticals USA, Inc. ($156.23) |
| 2018 | $1,045 | 36 | Genentech USA, Inc. ($181.88) |
| 2017 | $1,111 | 41 | Biogen, Inc. ($314.72) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Neuroscience | ||||||
| 08/27/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Neurology | ||||||
| 08/22/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Neuroscience | ||||||
| 07/25/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Neuroscience | ||||||
| 06/21/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Neuroscience | ||||||
| 06/20/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Neuromodulation | ||||||
| 06/13/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Neurology | ||||||
| 06/12/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 02/15/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Neuromodulation | ||||||
| 01/23/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Neuromodulation | ||||||
| 11/15/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: NEUROLOGY | ||||||
| 06/22/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: PSYCHIATRY | ||||||
| 05/16/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Immunology | ||||||
| 07/21/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Central Nervous System | ||||||
| 02/17/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/19/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: NEUROLOGY | ||||||
| 02/18/2020 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: NEUROLOGY | ||||||
| 01/24/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $113.97 | General |
| Category: Central Nervous System | ||||||
| 11/13/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $22.48 | General |
| Category: PARKINSONS DISEASE | ||||||
| 09/25/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $16.06 | General |
| Category: PARKINSONS DISEASE | ||||||
| 08/28/2019 | Akcea Therapeutics, Inc. | TEGSEDI (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: NEUROLOGY | ||||||
| 07/29/2019 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 112 | 164 | $51,319 | $19,466 |
| 2022 | 3 | 106 | 147 | $44,772 | $16,437 |
| 2021 | 3 | 130 | 175 | $52,421 | $19,914 |
| 2020 | 5 | 131 | 157 | $39,810 | $14,894 |
Total Patients
479
Total Services
643
Medicare Billing
$70,710
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 94 | $24,105 | $9,210 | 38.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 51 | 51 | $22,370 | $8,786 | 39.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 13 | 19 | $4,844 | $1,470 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 91 | $23,660 | $8,805 | 37.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 36 | 36 | $15,912 | $6,116 | 38.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 17 | 20 | $5,200 | $1,515 | 29.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 95 | $23,668 | $9,423 | 39.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 49 | 49 | $21,424 | $7,756 | 36.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 26 | 31 | $7,329 | $2,735 | 37.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 43 | 43 | $17,888 | $6,995 | 39.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 38 | 48 | $10,416 | $3,787 | 36.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 24 | 36 | $7,673 | $2,952 | 38.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 17 | $2,499 | $963.71 | 38.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 13 | 13 | $1,334 | $196.27 | 14.7% |
About Dr. John Orr, DO
Dr. John Orr, DO is a Neurology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104880046.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Orr, DO has received a total of $3,416 in payments from pharmaceutical and medical device companies, with $251.68 received in 2024. These payments were reported across 126 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,270).
As a Medicare-enrolled provider, Orr has provided services to 479 Medicare beneficiaries, totaling 643 services with total Medicare billing of $70,710. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Vascular Neurology
- Location Fort Worth, TX
- Active Since 04/17/2006
- Last Updated 07/14/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1104880046
Products in Payments
- TECFIDERA (Drug) $344.20
- TYSABRI (Biological) $285.29
- AJOVY (Drug) $276.29
- AUBAGIO (Drug) $258.66
- OCREVUS (Biological) $257.88
- NAMZARIC (Drug) $194.98
- Briviact (Drug) $149.35
- OXTELLAR XR (Drug) $126.11
- VUMERITY (Drug) $124.98
- Vimpat (Drug) $116.84
- AJOVY (Biological) $113.97
- Leqembi (Drug) $98.22
- APTIOM (Drug) $97.13
- AUSTEDO (Drug) $84.21
- INGREZZA (Drug) $79.35
- NUEDEXTA (Drug) $70.05
- INFINITY (Device) $66.59
- AMYVID (Drug) $54.72
- Gamunex-C (Biological) $52.08
- INBRIJA (Drug) $38.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fort Worth
Dr. Hamid Kadiwala, M.d, M.D
Neurology — Payments: $139,323
Neurology $139,323
Horacio Chiong-Rivero, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $83,086
Neurology $83,086
Sharique Ansari, M.d., Mph, M.D., MPH
Neurology — Payments: $79,831
Neurology $79,831
Krishnababu Chunduri, Md, MD
Neurology — Payments: $41,859
Neurology $41,859
Leila Bostan Shirin, M.d, M.D
Neurology — Payments: $35,690
Neurology $35,690
Jiangping Liu, Md, MD
Neurology — Payments: $33,262
Neurology $33,262